Specialty Pharmacy

Advance in lung cancer therapy achieved on molecular level.

Top news of the week on Specialty Pharmacy Times.

Mark Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses the impact of growing copay costs for patients on medication adherence.

Liver stiffness drops through sustained virological response at 24 weeks with hepatitis C antiviral drug regimen.

Xbox One Kinect platform shown to be effective helping walking gait issues in patient with multiple sclerosis.

Fevipiprant significantly decreased asthma symptoms.

Study finds use of digital health care platforms among growing population of senior citizens needs to improve.

Top news of the day from across the health care landscape.

Research analyzes HIV-positive individuals who naturally produce broadly neutralizing antibodies.

Drug to be evaluated combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer.

Ribociclib seeking indication for use in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer.

Specialty pharmacies must engage each individual patient to ensure optimal treatment outcomes.

Early treatment for multiple sclerosis found to delay relapse.

Improving data analytics could significantly speed up medical advances.

Sophisticated computer model illustrates that stopping hepatitis C within a single US state is a daunting task.

Group of molecules may present target to slow tumor growth in prostate cancer.

Top news of the day from across the health care landscape.

Combination antibody therapy may lead to new melanoma treatment strategy.

Simian immunodeficiency virus may be able to infect human cells.

Specialty pharmacies need to track drug pricing throughout the claims adjudication process to avoid potential liability.

Through a shell company, a New York pharmacist improperly billed Medicaid and others $274 million for illegally obtained HIV drugs.

Nusinersen significantly improved motor milestones and muscle function in spinal muscular atrophy (SMA) during phase 3 trial.

Microfluidic device may lead to new treatments for amyotrophic lateral sclerosis and other neuromuscular-related conditions.

Many conventional tests unable to detect resistance to antiretroviral drugs for HIV.

Mutant KRAS gene may lead to new therapies for lung cancer.

Top news of the day from across the health care landscape.

Early treatment of ovarian cancer is vital to survival.

Pharmacy medication synchronization programs may simplify care for diabetes and other chronic conditions.